Pierre Remy
Managing Partner @ Keensight Capital
Paris, France
Pierre Remy is a private equity investor at Keensight Capital in Paris focused on Biotechnology and Manufacturing. Pierre Remy is based out of Paris, Ile-de-France and is the Managing Partner of Keensight Capital. Pierre previously worked at Biovian as a Board Of Director. Pierre Remy attended the Sciences Po.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Pierre Remy invests in
Stages Pierre Remy invests in
Countries Pierre Remy invests in
Investment Focus
Industry
- Biotechnology 1 (100%)
- Manufacturing 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Unither Pharmaceuticals
|
Unither Pharmaceuticals is a French manufacturer of dosage forms for pharmaceutical laboratories, and generic products. The world leader in the contract manufacturing of pharmaceutical products. | Private Equity / Oct 26, 2022 |
Co-Investors
GIC
2 deals together
IK Partners
1 deal together
Parquest Capital
1 deal together
About Keensight Capital
Keensight Capital is a private equity and venture capital firm specializing in investments in mid venture, late venture, middle market, mezzanine financing, emerging growth, build-ups, and growth equity. The firm prefers to invest in the Internet, media and Information Technology, healthcare, energy and services, consumer, life sciences,information and communication technology, media, medical technology, and software sectors but may also consider investments other sectors. It seeks to invest in Europe with a focus on France and Italy. The firm makes equity investments for the provision of capital to finance growth, either organically or through acquisitions, or the cashing out of existing shareholders. The firm seeks to invest between €1 million ($1.29 million) and €30 million ($41.43 million) and participate in rounds of financing of up to €100 million ($128.86 million) through syndication. It invests in companies with revenues between €10 million ($13.75 million) and €150 million ($206.30 million). It takes both minority and majority shareholder positions in its portfolio companies with or without leverage. The firm prefers to have Board participation in its portfolio companies. Keensight Capital was founded in 2000 and is based in Paris, France.
Keensight Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Amit Karna
Partner
|
|||
Jerome Pujol
Managing Partner
|
|||
|
Pierre Remy
Managing Partner
|
|||
Adrien Van Eynde
CFO
|
|||
Anne de Bonnefon
Head of Investor Relations
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Pierre Remy invest in?
Pierre Remy invests primarily in Biotechnology, Manufacturing and Pharmaceutical startups, most often at Private Equity stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Pierre Remy last invest?
The most recent investment recorded for Pierre Remy closed in Oct 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
